Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
10.18
-0.92 (-8.29%)
At close: Dec 5, 2025, 4:00 PM EST
10.50
+0.32 (3.14%)
After-hours: Dec 5, 2025, 6:10 PM EST
Cadrenal Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 9.7 | 6.75 | 3.55 | 2.52 |
| Research & Development | 4.97 | 4.21 | 4.08 | 0.43 |
| Operating Expenses | 14.67 | 10.96 | 7.63 | 2.95 |
| Operating Income | -14.67 | -10.96 | -7.63 | -2.95 |
| Interest Expense | - | - | -0.02 | -0.12 |
| Interest & Investment Income | 0.29 | 0.31 | 0.25 | 0 |
| Other Non Operating Income (Expenses) | - | - | -0.22 | -4.26 |
| EBT Excluding Unusual Items | -14.39 | -10.65 | -7.62 | -7.32 |
| Other Unusual Items | - | - | -0.74 | - |
| Pretax Income | -14.39 | -10.65 | -8.36 | -7.32 |
| Net Income | -14.39 | -10.65 | -8.36 | -7.32 |
| Net Income to Common | -14.39 | -10.65 | -8.36 | -7.32 |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 |
| Shares Change (YoY) | 47.19% | 35.59% | 70.99% | - |
| EPS (Basic) | -8.19 | -8.73 | -9.29 | -13.92 |
| EPS (Diluted) | -8.19 | -8.73 | -9.29 | -13.92 |
| Free Cash Flow | -11.83 | -7.36 | -3.53 | -1.32 |
| Free Cash Flow Per Share | -6.74 | -6.04 | -3.93 | -2.50 |
| EBITDA | -14.67 | -10.96 | -7.63 | -2.95 |
| D&A For EBITDA | 0.01 | 0 | 0 | 0 |
| EBIT | -14.67 | -10.96 | -7.63 | -2.95 |
Source: S&P Capital IQ. Standard template.
Financial Sources.